Follow us on:
Breaking News
March 11, 2026
Breaking News
Breaking News
Adare_ENL_031126_650x90

Bausch + Lomb, Steriline Enter Sterile Ophthalmic Manufacturing Pact

 
Bausch + Lomb, Steriline Enter Sterile Ophthalmic Manufacturing Pact

New Annex 1–compliant filling line expands eye care production in Italy; additional systems planned for U.S. facilities.
Read More >>

Headlines

Breaking News

Lonza Divests Capsules & Health Ingredients Biz

Completes transformation to a pure-play CDMO.

SPONSOR

Advancing Oral Drug Delivery with 3DP

From rapid prototyping to commercial supply, Aprecia’s 3DP platform supports complex, differentiated oral products.

Breaking News
Collaborations & Alliances

GelMEDIX, Catalent Partner to Advance iPSC-Derived Cell Therapies

GelMEDIX gains access to Catalent’s proprietary, off-the-shelf, GMP-compliant iPSC lines and Catalent’s GMP iPSC and iPSC-derived cell therapy manufacturing capabilities.

Breaking News

Neuland Labs to Add Commercial Peptide Capacity with New India Facility in 2026

The new facility will enable client execution from small‑scale to multi‑ton commercial volumes.

SPONSOR

Smarter, Faster, More Reliable HPLC Performance

Shimadzu’s integrated LC combines powerful core features with automated functions to deliver superior data quality and drive productivity.

BoraPharmaceuticals_ENL_0326_650x250

Breaking News

Lonza, Genetix Bio Extend Commercial Mfg. Pact for ZYNTEGLO

Will expand manufacturing capacity at Lonza’s Houston facility to support growing demand for Genetix’s ZYNTEGLO.

SPONSOR

[VIDEO] Expanding Capacity for Next-Gen Biologics

Franco Negron of Simtra Biopharma Solutions shares insight on the sterile liquids manufacturing space.

Featured Resources

Solution Content Centers SPOTLIGHT

Solvias

Solvias is a global provider of CMC analytics to the pharmaceutical and biotech industry. Our expert teams combine 25 years of experience with regulatory understanding across small molecules, biologics, and cell and gene therapies. We offer comprehensive solutions from raw materials to drug substance & product to final release testing.

 

Solution Center SPOTLIGHT

PLD Pharma Services

PLD Pharma Services is a full-service CDMO providing end-to-end development and manufacturing for oral and solid dose Rx and OTC drugs across multiple delivery systems. With comprehensive R&D and analytical labs, an extensive formulation library, and a portfolio of more than 60 ANDAs, PLD supports products in solids, liquids, lozenges, and gummies. Backed by three decades of expertise, our integrated team advances programs from early concept through scale-up and commercial launch—all within a single, integrated team.